An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Newman, Aaron M, Bratman, Scott V, To, Jacqueline, Wynne, Jacob F, Eclov, Neville C W, Modlin, Leslie A, Liu, Chih Long, Neal, Joel W +6 more·2014·Nature Medicine
DOI 10.1038/nm.3519

Cited by (1,002)

Items 901–1,000 of 1,002

  1. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients
    Florian Janke, Arlou Kristina Angeles, Anja Lisa Riediger, Simone Bauer, Martin Reck, Albrecht Stenzinger, Marc Andre Schneider, Thomas Muley, Michael Thomas, Petros Christopoulos et al. · 2022 · Clinical Epigenetics
  2. Comparative analysis of genomic profiles between tissue-based and plasma-based next-generation sequencing in patients with non-small cell lung cancer
    Zeyun Lin, Yuqin Li, Shiqi Tang, Qiuhua Deng, Juhong Jiang, Chengzhi Zhou · 2023 · Lung Cancer
  3. Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer
    Óscar Rapado‐González, Ana María Rodríguez‐Ces, Rafael López‐López, María Mercedes Suárez‐Cunqueiro · 2023 · Japanese Dental Science Review
  4. Plasma methylated GNB4 and Riplet as a novel dual-marker panel for the detection of hepatocellular carcinoma
    Yanteng Zhao, Lei Zhao, Huifang Jin, Ying Xie, Liyinghui Chen, Wei Zhang, Lanlan Dong, Lianglu Zhang, Yue Huang, Kangkang Wan et al. · 2023 · Epigenetics
  5. Utilizing circulating tumour DNA in radiation oncology
    Ariana Rostami, Scott Victor Bratman · 2017 · Radiotherapy and Oncology
  6. Endonuclease IV based competitive DNA probe assay for differentiation of low-abundance point mutations by discriminating stable single-base mismatches
    Jiaju Xu, Longjie Li, Na Chen, Yongxin She, Shanshan Wang, Na Liu, Xianjin Xiao · 2017 · Chemical Communications
  7. Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
    Ariel E. E. Marciscano, Joshua M. Walker, Heather M. McGee, Michelle M. Kim, Charles A. Kunos, Arta Monir Monjazeb, Stephen Lawrence Shiao, Phuoc Tho Tran, Mansoor M. Ahmed · 2018 · Journal for ImmunoTherapy of Cancer
  8. New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies
    Irene Dogliotti, Daniela Drandi, Elisa Genuardi, Simone Ferrero · 2018 · Journal of Clinical Medicine
  9. Molecular characterization and biomarker identification in colorectal cancer: Toward realization of the precision medicine dream
    Gaurav Goel · 2018 · Cancer Management and Research
  10. The use of cell free DNA in the diagnosis of HCC
    Bubu A. Banini, Arun Jayant Sanyal · 2019 · Hepatoma Research
  11. Selecting short length nucleic acids localized in exosomes improves plasma EGFR mutation detection in NSCLC patients
    Yoonjung Kim, Saeam Shin, Boyeon Kim, Kyung‐A Lee · 2019 · Cancer Cell International
  12. Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN)
    Rachel Galot, Jean‐Pascal Machiels · 2020 · Cancer Treatment Reviews
  13. Performance evaluation method for read mapping tool in clinical panel sequencing
    Hojun Lee, Ki-Wook Lee, Taeseob Lee, Donghyun Park, Jongsuk Chung, Chung Lee, Woong‐Yang Park, Dae‐Soon Son · 2017 · Genes & Genomics
  14. TP53 and/or BRCA1 Mutations Based on CtDNA Analysis as Prognostic Biomarkers for Primary Triple-Negative Breast Cancer
    Akiko Arimura, Kazuko Sakai, Kazuhisa Kaneshiro, Takafumi Morisaki, Saori Hayashi, Kimihisa Mizoguchi, Mai Yamada, Masaya Kai, Mayumi Ono, Kazuto Nishio et al. · 2024 · Cancers
  15. Role of next‐generation sequencing in revolutionizing healthcare for cancer management
    Om Saswat Sahoo, Hiya Aidasani, Arnab Nayek, Smita Tripathi, Joyeeta Talukdar, Anamta Gul, Deepak Kumar, Ruby Dhar, Subhradip Karmakar · 2024 · MedComm – Future Medicine
  16. CRISPR/Cas12a Corona Nanomachine for Detecting Circulating Tumor Nucleic Acids in Serum
    Aijiao Yuan, T. R. Sun, Leyuan Chen, Dapeng Zhang, Wenjing Xie, Hanyong Peng · 2024 · Analytical Chemistry
  17. Translational Advances in Oncogene and Tumor-Suppressor Gene Research
    Radoslav Stojchevski, Edward Agus Sutanto, Rinni Sutanto, Nikola Hadzi‐Petrushev, Mitko I. Mladenov, S. P. Singh, Jitendra Kumar Sinha, Shampa Ghosh, Bhuvaneshwar Yarlagadda, Dr. Krishna Kumar Singh et al. · 2025 · Cancers
  18. Cell-Free DNA: Features and Attributes Shaping the Next Frontier in Liquid Biopsy
    Neeti Swarup, Ho Yeung Leung, Irene F. Choi, Mohammad Arshad Aziz, Jordan C. Cheng, David T. Wong · 2025 · Molecular Diagnosis & Therapy
  19. Circulating tumor DNA moves further into the spotlight
    Mark Sausen, Sonya Parpart, Luis Alberto Diaz · 2014 · Genome Medicine
  20. Detection of FGFR2 : FAM76A Fusion Gene in Circulating Tumor RNA Based on Catalytic Signal Amplification of Graphene Oxide‐loaded Magnetic Nanoparticles
    Lena Gorgannezhad, Muhammad Umer, Mostafa Kamal Masud, Md. Shahriar A. Hossain, Shunsuke Tanaka, Yusuke Yamauchi, Carlos Salomón, RICHARD C. KLINE, Nam‐Trung Nguyen, Muhammad J. A. Shiddiky · 2018 · Electroanalysis
  21. A Noninvasive and Donor-independent Method Simultaneously Monitors Rejection and Infection in Patients With Organ Transplant
    Yang Zhou, Gongda Yang, Haitao Liu, Ya–Wen Chen, Xiaofeng Li, Jun Ge, Xiaochen Wang, Haishan Niu, Wenzhao Dong, Tingya Jiang et al. · 2019 · Transplantation Proceedings
  22. Enrichment and Analysis of ctDNA
    Pauline Gilson · 2019 · Recent results in cancer research/Recent Results in Cancer Research
  23. Isolation and Retrieval of Extracellular Vesicles for Liquid Biopsy of Malignant Ground-Glass Opacity
    Wenjun Mao, Yi Wen, Haozhi Lei, Rongguo Lu, Shengfei Wang, Yuheng Wang, Ruo Chen, Yuanyuan Gu, Lin Zhu, Komal K. Abhange et al. · 2019 · Analytical Chemistry
  24. Parallel Serial Assessment of Somatic Mutation and Methylation Profile from Circulating Tumor DNA Predicts Treatment Response and Impending Disease Progression in Osimertinib-Treated Lung Adenocarcinoma Patients
    Shu Xia, Junyi Ye, Yu Chen, Analyn Lizaso, Le Huang, Lei Shi, Jing Su, Han Han‐Zhang, Shannon Chuai, Lingling Li et al. · 2019 · Translational Lung Cancer Research
  25. Clinical applications of liquid biopsies for early lung cancer detection.
    Hao Zheng, Xinyu Wu, Jie Yin, Shuang Wang, Zhi Li, Changxuan You · 2019 · PubMed Central
  26. Tiny but mighty: use of next generation sequencing on discarded cytocentrifuged bile duct brushing specimens to increase sensitivity of cytological diagnosis
    Aparna Harbhajanka, Claire W. Michael, Nafiseh Janaki, Hamza Numan Gokozan, Jay K. Wasman, Philip Bomeisl, Jennifer M. Yoest, Navid Sadri · 2020 · Modern Pathology
  27. The value of circulation tumor DNA in predicting postoperative recurrence of colorectal cancer: a meta-analysis
    Rui Ying Wang, Aiguang Zhao, Nida Cao, Zhaoyan Li, Guangtao Zhang, Feng Liu · 2020 · International Journal of Colorectal Disease
  28. Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platforms
    Thibaud Koessler, Viola Paradiso, Salvatore Piscuoglio, Ronny Nienhold, Liza K.F. Ho, Yann Christinat, Luigi Terracciano, Gieri Cathomas, Andreas N. WICKI, Thomas McKee et al. · 2020 · Laboratory Investigation
  29. Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management
    Aadel A. Chaudhuri, Bruna Pellini, Nadja Pejovic, Pradeep S. Chauhan, Peter K. W. Harris, Jeffrey J. Szymanski, Zachary L. Smith, Vivek K. Arora · 2020 · JCO Precision Oncology
  30. Differential Mutation Detection Capability Through Capture-Based Targeted Sequencing in Plasma Samples in Hepatocellular Carcinoma
    Jian Gao, Lei Xi, Rentao Yu, Huailong Xu, Min Wu, Hong Huang · 2021 · Frontiers in Oncology
  31. Assessment of Circulating Nucleic Acids in Cancer: From Current Status to Future Perspectives and Potential Clinical Applications
    Gabriella Cirmena, Martina Dameri, Francesco Ravera, Piero Fregatti, Alberto Ballestrero, Gabriele M. Zoppoli · 2021 · Cancers
  32. Liquid biopsies in pediatric oncology: opportunities and obstacles
    R. Taylor Sundby, Alexander C. Pan, Jack F. Shern · 2021 · Current Opinion in Pediatrics
  33. Challenges and Advances in Diagnosis and Treatment of Leptomeningeal Disease (LMD)
    Sherise Desiree Ferguson, Elena I. Fomchenko, Renato A. Guerrieri, Isabella C. Glitza Oliva · 2022 · Frontiers in Oncology
  34. Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome
    Chiara Favini, Donatella Talotta, Mohammad Almasri, Annalisa Andorno, Silvia Rasi, Ramesh Adhinaveni, Sreekar Kogila, Bassel Awikeh, Mattia Schipani, Paola Boggione et al. · 2022 · British Journal of Haematology
  35. Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
    Samaneh Eickelschulte, Anja Lisa Riediger, Arlou Kristina Angeles, Florian Janke, Stefan M. Duensing, Holger Sültmann, Magdalena Görtz · 2022 · Cancers
  36. Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits
    M. Alcaide, Stephen L. Yu, J. Davidson, Marco Albuquerque, K. Bushell, D. Fornika, S. Arthur, B. Grande, S. McNamara, M. C. du Tertre et al. · 2017 · Scientific Reports
  37. The identification and isolation of CTCs: A biological Rubik’s cube
    Cristina Mansilla, Elena Soria, Natalia Ramírez · 2018 · Critical Reviews in Oncology/Hematology
  38. Ultra-deep massively parallel sequencing with unique molecular identifier tagging achieves comparable performance to droplet digital PCR for detection and quantification of circulating tumor DNA from lung cancer patients
    Le Son Tran, Hong-Anh Thi Pham, Vu-Uyen Tran, Thanh-Truong Tran, Anh-Thu Huynh Dang, Dinh-Thong Vu Le, Son-Lam Vu Nguyen, Ngoc Vu Nguyen, Trieu-Vu Nguyen, Binh Thanh Vo et al. · 2019 · PLoS ONE
  39. Circulating Tumor DNA Testing for Minimal Residual Disease and Its Application in Colorectal Cancer
    Oluseyi Abidoye, Daniel H. Ahn, Mitesh J. Borad, Christina Wu, Tanios Bekaii‐Saab, Sakti Chakrabarti, Mohamad Bassam Sonbol · 2025 · Cells
  40. Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders
    Mao Yang, Yuhao Zhao, Chen Li, Xiaoling Weng, Zhizhen Li, Wu Guo, Wenning Jia, Feiling Feng, Jiaming Hu, Haonan Sun et al. · 2025 · Cancer Cell
  41. Circulating Tumor DNA detection in cancer: a comprehensive overview of current detection methods and prospects
    Ana Regina de Abreu, Ayla Wyninckx, Timon Vandamme, Ken Op de Beeck, Guy Van Camp, Marc Peeters, Pierre Laurent‐Puig, Julien Taı̈eb, Valérie Taly, Léonor Benhaïm · 2025 · The Oncologist
  42. Mission critical: the need for proteomics in the era of next-generation sequencing and precision medicine
    Devon M. Cayer, Kristopher L. Nazor, Nicholas J. Schork · 2016 · Human Molecular Genetics
  43. Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis
    Chang Gon Kim, Hyo Sup Shim, Min Hee Hong, Yoon Jin Cha, Su Jin Heo, Hyung Soon Park, Jee Hung Kim, Jin Gu Lee, Chang Young Lee, Byoung Chul Cho et al. · 2017 · Oncotarget
  44. Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing
    Nanae Masunaga, Naofumi Kagara, Daisuke Motooka, Shota Nakamura, Tomohiro Miyake, Tomonori Tanei, Yasuto Naoi, Masafumi Shimoda, Kenzo Shimazu, Seung Jin Kim et al. · 2017 · Breast Cancer Research and Treatment
  45. The future of cell-free DNA testing to guide therapeutic decisions in B-cell lymphomas
    Adalgisa Condoluci, Davide Rossi · 2019 · Current Opinion in Hematology
  46. Undetectable circulating tumor DNA levels correlate with low risk of recurrence/metastasis in postoperative pathologic stage I lung adenocarcinoma patients
    Weixiong Yang, Na You, Minghan Jia, Sai‐Ching J. Yeung, Wei Ou, Man Yu, Yinguang Wang, Xiayu Fu, Zhanfei Zhang, Jiali Yang et al. · 2020 · Lung Cancer
  47. Liquid Biopsy and Their Application Progress in Head and Neck Cancer: Focus on Biomarkers Ctcs, Cfdna, Ctdna and Evs
    Yiling Meng, Lei Bian, Meichao Zhang, Fang Bo, Xiao Lu, Dong Li · 2020 · Biomarkers in Medicine
  48. An enzyme-free amplification strategy for sensitive assay of circulating tumor DNA based on wheel-like catalytic hairpin assembly and frame hybridization chain reaction
    Shihua Luo, Ye Zhang, Guoni Huang, Bo Situ, Xinyi Ye, Maliang Tao, Yifang Huang, Bo Li, Xiujuan Jiang, Qian Wang et al. · 2021 · Sensors and Actuators B Chemical
  49. Earlier extracranial progression and shorter survival in ALK- rearranged lung cancer with positive liquid rebiopsies
    Petros Christopoulos, Steffen Dietz, Arlou Kristina Angeles, Stephan Rheinheimer, Daniel N. Kazdal, Anna‐Lena Volckmar, Florian Janke, Volker Endris, Michael A. Meister, Mark Kriegsmann et al. · 2021 · Translational Lung Cancer Research
  50. CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M–positive lung cancer after osimertinib
    Ryoji Kato, Hidetoshi Hayashi, Kazuko Sakai, Shinichiro Suzuki, Koji Haratani, Takayuki Takahama, Junko Tanizaki, Yoshikane Nonagase, Kaoru Tanaka, Takeshi Yoshida et al. · 2021 · International Journal of Clinical Oncology
  51. Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA
    Kuniko Sunami, Hideaki Bando, Yasushi Yatabe, Yoichi Naito, Hideaki E. Takahashi, Katsuya Tsuchihara, Shinichi Toyooka, Koshi Mimori, Shinji Kohsaka, Hiroyuki Uetake et al. · 2021 · Cancer Science
  52. Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma
    Bethany L. Mundy-Bosse, Christoph Weigel, Yue-Zhong Wu, Salma Abdelbaky, Youssef Youssef, Susana Beceiro Casas, Nicholas Polley, Gabrielle Ernst, Karen A. Young, Kathleen K. McConnell et al. · 2022 · Blood Cancer Discovery
  53. The Clinical Applications of Liquid Biopsies in Pediatric Brain Tumors: A Systematic Literature Review
    Ladina Greuter, Nicole Alexandra Frank, Raphael G Guzman, Jehuda Soleman · 2022 · Cancers
  54. Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies
    Nicholas Mikolajewicz, Shahbaz Khan, Mara D. Trifoi, Anna Skakdoub, Vladmir Ignatchenko, Sheila Mansouri, Jeffrey Zuccato, Brad E. Zacharia, Michael Glantz, Gelareh Mohammed Zadeh et al. · 2022 · Neuro-Oncology Advances
  55. Application and development of noninvasive biomarkers for colorectal cancer screening: a systematic review
    Dan Song, Fei Wang, Yongzhi Ju, Qianru He, Tingting Sun, Wanglong Deng, Ran Ding, Chao Zhang, Qing Xu, Chuang Qi et al. · 2023 · International Journal of Surgery
  56. The Early Diagnosis of Lung Cancer: Critical Gaps in the Discovery of Biomarkers
    Roberto Gasparri, Angela Sabalic, Lorenzo Spaggiari · 2023 · Journal of Clinical Medicine
  57. Evaluation of digital PCR for detecting low-level EGFR mutations in advanced lung adenocarcinoma patients: a cross-platform comparison study
    Jincui Gu, Wanchun Zang, Bing Liu, Lei Li, Lixia Huang, Shaoli Li, Guanhua Rao, Yang Yu, Yanbin Zhou · 2017 · Oncotarget
  58. Cell-free DNA in non-small cell lung cancer
    Vaida Gedvilaitė, Diana Schveigert, Saulius Cicėnas · 2017 · Acta medica Lituanica
  59. Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
    Xiaoxing Lv, Meiru Zhao, Yuting Yi, Lucheng Zhang, Yanfang Guan, Tao Liu, Ling Mei Yang, Rongrong Chen, Jianhui Ma, Xin Yi · 2017 · Journal of Visualized Experiments
  60. Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization
    Michael Patrick MacManus, Sarah Everitt, Tanja Schimek‐Jasch, Xuyang Li, Ursula Nestle, Feng‐Ming Kong · 2017 · Translational Lung Cancer Research
  61. Treatment of EGFR T790M-Positive Non-Small Cell Lung Cancer
    Joan Rou-En Choo, Chee‐Seng Tan, Ross Andrew Soo · 2018 · Targeted Oncology
  62. Cancer liquid biopsies by Oxford Nanopore Technologies sequencing of cell-free DNA: from basic research to clinical applications
    Huaqi Si, Peng Wang, Fei Long, Wei Zhong, Yuan-Dong Meng, Yuan Rong, Xiangyu Meng, Fubing Wang · 2024 · Molecular Cancer
  63. Management of Egfr-Mutated Non-Small-Cell Lung Cancer: Practical Implications from a Clinical and Pathology Perspective
    Michael Cabanero, Randeep S. Sangha, Brandon S. Sheffield, Mahadeo A. Sukhai, Mini Pakkal, Suzanne Kamel‐Reid, Aly Karsan, Diana N. Ionescu, Rosalyn Anne Juergens, Charles Andrew Butts et al. · 2017 · Current Oncology
  64. Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics
    In Sil Choi, Shumei Kato, Paul Timothy Fanta, Lawrence Leichman, Ryosuke Okamura, Victoria M. Raymond, Richard Burnham Lanman, Scott Michael Lippman, Razelle Kurzrock · 2019 · Molecular Cancer Therapeutics
  65. Induction of apoptosis increases sensitivity to detect cancer mutations in plasma
    Joana F. Marques, Susana Junqueira-Neto, Jorge Pinheiro, José Carlos Machado, José Luís Costa · 2020 · European Journal of Cancer
  66. Current status and future perspectives of liquid biopsy in non-small cell lung cancer
    Sun Hee Chang, Jae Young Hur, Yoon‐La Choi, Chang Hun Lee, Wan Seop Kim · 2020 · Journal of Pathology and Translational Medicine
  67. Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology
    Gregor Hoermann, Georg Greiner, Andrea Griesmacher, Peter Valent · 2020 · Journal of Personalized Medicine
  68. RNF213 gene mutation in circulating tumor DNA detected by targeted next‐generation sequencing in the assisted discrimination of early‐stage lung cancer from pulmonary nodules
    Ning Jiang, Jie Zhou, Wenhao Zhang, Peichao Li, Yu Liu, Hubo Shi, Chengke Zhang, Yunshan Wang, Chengjun Zhou, Chuanliang Peng et al. · 2020 · Thoracic Cancer
  69. Post‑radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma
    Ru Jia, Chuanhua Zhao, Pan-Song Li, Rongrui Liu, Yun Zhang, Hai-E Chen, Lianpeng Chang, Yuhua Gong, Yanfang Guan, Xin Yi et al. · 2020 · Oncology Letters
  70. Mn2+-mediated magnetic relaxation switching for direct assay of ctDNA in whole blood via exonuclease III assisted amplification
    Yunyun Hu, Xin Wen Guo, Peilin Gu, Qin Luo, Yang Song, Erqun Song · 2020 · Sensors and Actuators B Chemical
  71. Can integrative biomarker approaches improve prediction of platinum and PARP inhibitor response in ovarian cancer?
    Funingana, Ionut-Gabriel, Reinius, Marika A.V., Petrillo, Angelica, Ang, Joo Ern, Brenton, James D. · 2021 · Seminars in Cancer Biology
  72. Roadmap on plasticity and epigenetics in cancer
    Jasmine Foo, David Basanta, Russell C. Rockne, Carly Strelez, Curran A. Shah, Kimya Ghaffarian, Shannon M. Mumenthaler, Kelly Mitchell, Justin Durla Lathia, David Eugene Frankhouser et al. · 2022 · Physical Biology
  73. Circulating tumour DNA: a challenging innovation to develop “precision onco-surgery” in pancreatic adenocarcinoma
    Daniel Pietrasz, Elisabetta Sereni, Francesco Lancellotti, Antonio Pea, Claudio Luchini, Giulio Innamorati, Roberto Salvia, Claudio Bassi · 2022 · British Journal of Cancer
  74. Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
    Nobuyuki Chikuie, Yuji Urabe, Tsutomu Ueda, Takao Hamamoto, Takayuki Taruya, Takashi Kono, Kohei Yumii, Sachio Takeno · 2022 · Scientific Reports
  75. Parallel Analysis of Pre- and Postoperative Circulating Tumor DNA and Matched Tumor Tissues in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study
    Jee-Soo Lee, Youngmin Han, Won‐Gun Yun, Wooil Kwon, Hongbeom Kim, Hyeonju Jeong, Myoung-Seock Seo, Yongsook Park, Sung Im Cho, Haeryoung Kim et al. · 2022 · Clinical Chemistry
  76. Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden
    Kwang Seob Lee, Jieun Seo, Choong‐kun Lee, Saeam Shin, Zisun Choi, Seungki Min, Jun Hyuek Yang, Woo Sun Kwon, Woobin Yun, Mi Ri Park et al. · 2022 · Clinical Chemistry
  77. Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review
    Collin Michael Blakely, Walter Weder, Lukas Bubendorf, Jianxing He, Margarita Majem, Yu Shyr, Jamie E. Chaft · 2023 · Lung Cancer
  78. Comprehensive clinical assays for molecular diagnostics of gliomas: the current state and future prospects
    Alina O. Penkova, Olga Kuziakova, Valeriia S. Gulaia, Vladlena Tiasto, Nikolay V. Goncharov, Daria Lanskikh, Valeriia Zhmenia, Ivan Baklanov, Vladislav M. Farniev, Vadim Vladimirovich Kumeiko · 2023 · Frontiers in Molecular Biosciences
  79. Clinical applications and perspectives of circulating tumor DNA in gastric cancer
    J M Li, Danying Zhang, Ji‐Min Zhu, Ling Dong · 2024 · Cancer Cell International
  80. Diagnostic Challenges in Non-Small-Cell Lung Cancer: An Integrated Medicine Approach
    Ravi Salgia · 2015 · Future Oncology
  81. Management of Resistance to Crizotinib in Anaplastic Lymphoma Kinase-Positive Non–Small-cell Lung Cancer
    Alexios Matikas, Nikolaos K. Kentepozidis, Vassilis Georgoulias, Athanasios Panayotis Kotsakis · 2016 · Clinical Lung Cancer
  82. The In Vitro Stability of Circulating Tumour DNA
    Emanuela Henao Diaz, Jeffrey Yachnin, Henrik Grönberg, Johan Lindberg · 2016 · PLoS ONE
  83. Future perspectives of circulating tumor DNA in colorectal cancer
    Cristina Nadal, Thomas L. Winder, Armin Gerger, David Tougeron · 2017 · Tumor Biology
  84. High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation Sequencing
    Yinghui Guan, Oleg Mayba, Thomas Sandmann, Shan Lu, YounJeong Choi, Walter C. Darbonne, Vincent Lévêque, Lisa C. Ryner, Eric William Humke, Nga Wan Rachel Tam et al. · 2017 · Journal of Molecular Diagnostics
  85. Circulating Tumor DNA in Non–Small-Cell Lung Cancer: A Primer for the Clinician
    Aditi Puri Singh, Haiying Cheng, Xiaoling Guo, Benjamin Philip Levy, Balázs Halmos · 2017 · JCO Precision Oncology
  86. New targets and therapies for gastrointestinal stromal tumors
    Agnieszka Woźniak, Yemarshet Kelemework Gebreyohannes, Maria Dêbiec‐Rychter, Patrick Schöffski · 2017 · Expert Review of Anticancer Therapy
  87. Analysis of solid tumor mutation profiles in liquid biopsy
    Sai Balaji Andugulapati, Ashwini Shanmugam, Anuradha Chougule, Srikant Sridharan, Kumar Prabhash, Anuradha Arya, Aditya Chaubey, Arun K Hariharan, Pandurang S. Kolekar, Manimala Sen et al. · 2018 · Cancer Medicine
  88. Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?
    Wafik S. El‐Deiry, Barry S. Taylor, Joel W. Neal · 2017 · American Society of Clinical Oncology Educational Book
  89. Toward liquid biopsies in cancer treatment: application of circulating tumor DNA
    Lise Barlebo Ahlborn, Oľga Østrup · 2019 · Apmis
  90. Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients
    Pei Meng, Jiacong Wei, Yiqun Geng, Shaobin Chen, Miente Martijn Terpstra, Qiongyi Huang, Qian Zhang, Zuoqing Su, Wanchun Yu, Min Su et al. · 2019 · BMC Cancer
  91. Review and perspective on adjuvant and neoadjuvant immunotherapies in NSCLC
    Chengxiang Yi, Yayi He, Haoran Xia, Helin Zhang, Peng Zhang · 2019 · OncoTargets and Therapy
  92. Applications of liquid biopsy in lung cancer-diagnosis, prognosis prediction, and disease monitoring.
    Wenna Luo, Mingliang Rao, Jiayao Qu, Dixian Luo · 2018 · Europe PMC (PubMed Central)
  93. Fragment Enrichment of Circulating Tumor DNA With Low-Frequency Mutations
    Xiaojun Liu, Jidong Lang, Shijun Li, Yuehua Wang, Lihong Peng, Weitao Wang, Yingmin Han, Cuixiao Qi, Lei Song, Shuangshuang Yang et al. · 2020 · Frontiers in Genetics
  94. Surgery after neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer
    Caroline Huynh, Logan A. Walsh, Jonathan David Spicer · 2021 · Translational Lung Cancer Research
  95. Combined assay of Circulating Tumor DNA and Protein Biomarkers for early noninvasive detection and prognosis of Non-Small Cell Lung Cancer
    Jianxin Yin, Wenwei Hu, Hua Gu, Jianmin Fang · 2021 · Journal of Cancer
  96. Sequencing Illumina libraries at high accuracy on the ONT MinION using R2C2
    Alexander Zee, Dori Z.Q. Deng, Matthew S. Adams, Kayla D. Schimke, Russell B Corbett-Detig, Shelbi L. Russell, Xuan Zhang, Robert J. Schmitz, Christopher Vollmers · 2022 · Genome Research
  97. Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma
    Hitomi Hosoya, Mia A. Carleton, Kailee L. Tanaka, Brian J. Sworder, Shriya Syal, Bita Sahaf, Alisha M. Birk, Oscar Silva, Henning Stehr, Vanna N. Hovanky et al. · 2025 · Nature Communications
  98. Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA
    Michael David Offin, Jacob J. Chabon, Pedram Razavi, James M. Isbell, Charles M. Rudin, Maximilian Diehn, Bob T. Li · 2017 · Journal of Oncology
  99. Engineering Multidimensional Evolutionary Forces to Combat Cancer
    Caroline Elizabeth McCoach, Trever Grant Bivona · 2019 · Cancer Discovery
  100. TNER: a novel background error suppression method for mutation detection in circulating tumor DNA
    Shibing Deng, Maruja Lira, Donghui Huang, Kai Wang, Crystal E. Valdez, Jennifer Kinong, Paul A. Rejto, Jadwiga Renata Bienkowska, James S. Hardwick, Tao Xie · 2018 · BMC Bioinformatics